Page last updated: 2024-10-27

flumazenil and Aura

flumazenil has been researched along with Aura in 71 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research Excerpts

ExcerptRelevanceReference
"Clobazam (CLB), a 1,5-benzodiazepine, is a remarkably effective add-on drug for individual patients with refractory partial epilepsy."8.79Clobazam for treatment of intractable epilepsy: a critical assessment. ( Schmidt, D, 1994)
"The aim of the present study was to investigate if flumazenil blood-brain barrier transport and binding to the benzodiazepine site on the γ-aminobutyric acid A (GABA(A)) receptor complex is altered in an experimental model of epilepsy and subsequently to study if changes in P-glycoprotein (P-gp)-mediated efflux of flumazenil at the blood-brain barrier may confound interpretation of (11)C-flumazenil PET in epilepsy."7.78Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET. ( de Lange, EC; Eriksson, J; Labots, M; Lammertsma, AA; Syvänen, S; Tagawa, Y; Voskuyl, RA; Windhorst, AD, 2012)
"To investigate changes in free benzodiazepine receptor density in response to repeated, long-term administration of diazepam in epilepsy, we assessed 125I-iomazenil (125I-IMZ) binding in a mouse model."7.73Effects of diazepam on 125I-iomazenil-benzodiazepine receptor binding and epileptic seizures in the El mouse. ( Fukumitsu, N; Mori, Y; Ogi, S; Uchiyama, M, 2006)
"Twelve adult patients considered for epilepsy surgery with medically intractable temporal lobe epilepsy (TLE; n = 7), extratemporal lobe epilepsy (ETE; n = 2), and TLE+ETE (n = 3) were prospectively examined with DWI interictally (serving as baseline) and 10 min after application of 1 mg flumazenil i."7.72Presurgical evaluation of epilepsy by brain diffusion: MR-detected effects of flumazenil on the epileptogenic focus. ( de Greiff, A; Diener, HC; Dörfler, A; Hufnagel, A; Konermann, S; Leonhardt, G; Ludwig, T; Marks, S; Weber, J; Wiedemayer, H, 2003)
"Using [11C]flumazenil (FMZ)-positron emission tomography (PET) imaging, 15 children (aged 1-8 years) with medically intractable epilepsy were studied."7.71Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy. ( Chugani, DC; Chugani, HT; Janisse, J; Juhász, C; Muzik, O; Shen, C, 2001)
"The protective and adverse effect potentials of levetiracetam ((S)-alpha-ethyl-2-oxo-pyrrolidine acetamide) in rodent models of seizures and epilepsy were compared with the profile of several currently prescribed and newly developed antiepileptic drugs."7.70Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. ( Gobert, J; Klitgaard, H; Matagne, A; Wülfert, E, 1998)
"[11C]flumazenil (FMZ) PET is significantly more sensitive than 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET for the detection of cortical regions of seizure onset and frequent spiking in patients with extratemporal lobe epilepsy, whereas both FDG and FMZ PET show low sensitivity in the detection of cortical areas of rapid seizure spread."7.70Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. ( Canady, A; Chugani, DC; Chugani, HT; da Silva, EA; Frost, M; Gates, J; Herholz, K; Juhasz, C; Muzik, O; Nagy, F; Ritter, F; Shah, J; von Stockhausen, HM; Watson, C, 2000)
"To analyze the clinical utility of [11C]flumazenil (FMZ) PET to detect perilesional and remote cortical areas of abnormal benzodiazepine receptor binding in relation to MRI, 2-deoxy-2-[18F]fluoro-d-glucose (FDG) PET, and electrocorticographic (ECoG) findings as well as clinical characteristics of the epilepsy in epileptic patients with brain lesion."7.70Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. ( Chugani, DC; Chugani, HT; Juhász, C; Muzik, O; Shah, A; Shah, J; Watson, C, 2000)
"The mechanisms underlying tolerance to benzodiazepines were investigated by injecting diazepam (5 mg/kg) twice daily for 23 days in WAG/Rij rats (an animal model for non-convulsive absence epilepsy)."7.68Diazepam and Ro 15-1788 increase absence epilepsy in WAG/Rij rats chronically exposed to diazepam. ( Coenen, AM; Nutt, DJ; Peeters, BW; Titulaer, MN; Van Rijn, CM; Vossen, JM, 1990)
"In PTZ-induced epileptic seizures, the i."5.33Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. ( Hosseinzadeh, H; Mansouri, MT; Nassiri-Asl, M; Parvardeh, S, 2005)
"The effect on interictal EEG epileptic activity (IEA) of oral flumazenil, a benzodiazepine antagonist and potential antiepileptic drug, was studied in 12 adults with refractory epilepsy."5.07The effect of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled study. ( Sander, JW; Sharief, MK; Shorvon, SD, 1993)
"Clobazam (CLB), a 1,5-benzodiazepine, is a remarkably effective add-on drug for individual patients with refractory partial epilepsy."4.79Clobazam for treatment of intractable epilepsy: a critical assessment. ( Schmidt, D, 1994)
"The aim of the present study was to investigate if flumazenil blood-brain barrier transport and binding to the benzodiazepine site on the γ-aminobutyric acid A (GABA(A)) receptor complex is altered in an experimental model of epilepsy and subsequently to study if changes in P-glycoprotein (P-gp)-mediated efflux of flumazenil at the blood-brain barrier may confound interpretation of (11)C-flumazenil PET in epilepsy."3.78Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET. ( de Lange, EC; Eriksson, J; Labots, M; Lammertsma, AA; Syvänen, S; Tagawa, Y; Voskuyl, RA; Windhorst, AD, 2012)
"To investigate changes in free benzodiazepine receptor density in response to repeated, long-term administration of diazepam in epilepsy, we assessed 125I-iomazenil (125I-IMZ) binding in a mouse model."3.73Effects of diazepam on 125I-iomazenil-benzodiazepine receptor binding and epileptic seizures in the El mouse. ( Fukumitsu, N; Mori, Y; Ogi, S; Uchiyama, M, 2006)
"Twelve adult patients considered for epilepsy surgery with medically intractable temporal lobe epilepsy (TLE; n = 7), extratemporal lobe epilepsy (ETE; n = 2), and TLE+ETE (n = 3) were prospectively examined with DWI interictally (serving as baseline) and 10 min after application of 1 mg flumazenil i."3.72Presurgical evaluation of epilepsy by brain diffusion: MR-detected effects of flumazenil on the epileptogenic focus. ( de Greiff, A; Diener, HC; Dörfler, A; Hufnagel, A; Konermann, S; Leonhardt, G; Ludwig, T; Marks, S; Weber, J; Wiedemayer, H, 2003)
" In a prospective trial in dogs with newly diagnosed epilepsy, ELB 138 markedly reduced seizure frequency and severity without significant difference to standard treatments (phenobarbital or primidone) but was much better tolerated than the standard drugs."3.72Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures. ( Löscher, W; Potschka, H; Rieck, S; Rundfeldt, C; Tipold, A, 2004)
"Using [11C]flumazenil (FMZ)-positron emission tomography (PET) imaging, 15 children (aged 1-8 years) with medically intractable epilepsy were studied."3.71Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy. ( Chugani, DC; Chugani, HT; Janisse, J; Juhász, C; Muzik, O; Shen, C, 2001)
"[11C]flumazenil (FMZ) PET is significantly more sensitive than 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET for the detection of cortical regions of seizure onset and frequent spiking in patients with extratemporal lobe epilepsy, whereas both FDG and FMZ PET show low sensitivity in the detection of cortical areas of rapid seizure spread."3.70Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. ( Canady, A; Chugani, DC; Chugani, HT; da Silva, EA; Frost, M; Gates, J; Herholz, K; Juhasz, C; Muzik, O; Nagy, F; Ritter, F; Shah, J; von Stockhausen, HM; Watson, C, 2000)
"The protective and adverse effect potentials of levetiracetam ((S)-alpha-ethyl-2-oxo-pyrrolidine acetamide) in rodent models of seizures and epilepsy were compared with the profile of several currently prescribed and newly developed antiepileptic drugs."3.70Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. ( Gobert, J; Klitgaard, H; Matagne, A; Wülfert, E, 1998)
"To analyze the clinical utility of [11C]flumazenil (FMZ) PET to detect perilesional and remote cortical areas of abnormal benzodiazepine receptor binding in relation to MRI, 2-deoxy-2-[18F]fluoro-d-glucose (FDG) PET, and electrocorticographic (ECoG) findings as well as clinical characteristics of the epilepsy in epileptic patients with brain lesion."3.70Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. ( Chugani, DC; Chugani, HT; Juhász, C; Muzik, O; Shah, A; Shah, J; Watson, C, 2000)
"Using [11C]flumazenil-PET and statistical parametric mapping (SPM), we have shown recently that regions of increased and decreased benzodiazepine receptor density may be seen in patients with localization-related epilepsy due to malformations of cortical development."3.69Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. ( Ashburner, J; Brooks, DJ; Duncan, JS; Free, SL; Friston, KJ; Koepp, MJ; Richardson, MP; Sisodiya, SM, 1997)
"We objectively delineated the extent of abnormalities in central benzodiazepine receptor (cBZR) binding using [11C]flumazenil (FMZ)-PET and high resolution volumetric MRI in 12 patients with mesial temporal lobe epilepsy (mTLE) associated with unilateral hippocampal sclerosis, who underwent presurgical evaluation and subsequent temporal lobe surgery."3.69Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. ( Brooks, DJ; Duncan, JS; Friston, KJ; Koepp, MJ; Poline, JB; Richardson, MP; Van Paesschen, W, 1996)
"The mechanisms underlying tolerance to benzodiazepines were investigated by injecting diazepam (5 mg/kg) twice daily for 23 days in WAG/Rij rats (an animal model for non-convulsive absence epilepsy)."3.68Diazepam and Ro 15-1788 increase absence epilepsy in WAG/Rij rats chronically exposed to diazepam. ( Coenen, AM; Nutt, DJ; Peeters, BW; Titulaer, MN; Van Rijn, CM; Vossen, JM, 1990)
"The clinical anti-convulsant effect of flumazenil in epilepsy has been demonstrated: (i) by acute i."3.67The clinical anti-convulsant effects of flumazenil, a benzodiazepine antagonist. ( Scollo-Lavizzari, G, 1988)
"When flumazenil (3 mg) was administered immediately after intravenous diazepam (10 mg), the reduction in interictal epileptic activity was not significantly different from that produced by diazepam alone."2.67The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study. ( Hart, YM; Meinardi, H; Nutt, DJ; Sander, JW; Shorvon, SD, 1991)
"Most complex seizures arise from the temporal lobes and the condition of 20-30% of these patients is refractory to medication."2.41[Functional imaging (PET and SPECT) in epilepsy]. ( Borbély, K, 2001)
"Epilepsy was seen by some as a divine punishment or resulting from black magic."1.56Traditional practices and perceptions of epilepsy among people in Roma communities in Bulgaria. ( Antimov, P; Sander, JW; Tournev, I; Zhelyazkova, S, 2020)
"Kainic acid (KA) solution was injected stereotaxically into medial and lateral sites of the sensori-motor cortex."1.33Focal cortical dysplasia: pathophysiological approach. ( Hashizume, K; Hodozuka, A; Tanaka, T; Tsuda, H, 2006)
" Mean population pharmacokinetic parameters (percent coefficient of variation) were: CL 1530 mL min(-1) (6."1.33Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations. ( Franssen, EJ; Greuter, HN; Huitema, AD; Lammertsma, AA; Swart, EL; van Loenen, AC; van Rij, CM, 2005)
"In PTZ-induced epileptic seizures, the i."1.33Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. ( Hosseinzadeh, H; Mansouri, MT; Nassiri-Asl, M; Parvardeh, S, 2005)
" Marked differences in drug sensitivity were observed between models based on single and chronic administration of PTZ showing that the two sets of models are fundamentally different."1.32Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. ( Hansen, SL; Sánchez, C; Sperling, BB, 2004)
"[11C]flumazenil was found to be a more sensitive and accurate focus localiser than [18F]FDG."1.29Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. ( Ingvar, M; Savic, I; Stone-Elander, S, 1993)
"Flumazenil was without effect on normal synaptic responses; however, flumazenil reduced epileptiform discharges evoked in the presence of high [K+]o, leu-enkephalin, the BZR inverse agonist, methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), or after a cold-shock procedure."1.29Benzodiazepine antagonists reduce epileptiform discharges in rat hippocampal slices. ( Carlen, PL; Facciponte, G; Jahromi, SS; Pelletier, MR; Polc, P; Zhang, L, 1996)

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-19904 (5.63)18.7374
1990's29 (40.85)18.2507
2000's26 (36.62)29.6817
2010's10 (14.08)24.3611
2020's2 (2.82)2.80

Authors

AuthorsStudies
Niu, N1
Xing, H1
Wu, M1
Ma, Y1
Liu, Y1
Ba, J1
Zhu, S1
Li, F1
Huo, L1
Erfanparast, A1
Tamaddonfard, E1
Henareh-Chareh, F1
Fujimoto, A1
Okanishi, T1
Kanai, S1
Sato, K1
Itamura, S1
Baba, S1
Nishimura, M1
Masui, T1
Enoki, H1
de Almeida, RN1
de Sousa, DP1
Nóbrega, FF1
Claudino, Fde S1
Araújo, DA1
Leite, JR1
Mattei, R1
Liefaard, LC1
Ploeger, BA1
Molthoff, CF1
de Jong, HW1
Dijkstra, J1
van der Weerd, L1
Lammertsma, AA3
Danhof, M1
Voskuyl, RA2
Liu, DS1
O'Brien, TJ1
Williams, DA1
Hicks, RJ1
Myers, DE1
Horky, LL1
Treves, ST1
Higurashi, N1
Hamano, S1
Oritsu, T1
Minamitani, M1
Sasaki, M1
Ida, H1
Mori, T1
Mori, K1
Fujii, E1
Toda, Y1
Miyazaki, M1
Harada, M1
Kagami, S1
Kuki, I2
Kawawaki, H2
Okazaki, S2
Inoue, T1
Nukui, M1
Tomiwa, K2
Amou, K1
Togawa, M1
Shiomi, M1
Kato, H2
Matsuda, K2
Baba, K1
Shimosegawa, E2
Isohashi, K1
Imaizumi, M1
Hatazawa, J2
Syvänen, S1
Labots, M1
Tagawa, Y1
Eriksson, J1
Windhorst, AD1
de Lange, EC1
da Cruz, GM1
Felipe, CF1
Scorza, FA1
da Costa, MA1
Tavares, AF1
Menezes, ML1
de Andrade, GM1
Leal, LK1
Brito, GA1
da Graça Naffah-Mazzacoratti, M1
Cavalheiro, EA1
de Barros Viana, GS1
Konermann, S1
Marks, S1
Ludwig, T1
Weber, J1
de Greiff, A1
Dörfler, A1
Leonhardt, G1
Wiedemayer, H1
Diener, HC1
Hufnagel, A1
Csaba, J1
Levêque, P1
Sanabria-Bohorquez, S1
Bol, A1
De Volder, A1
Labar, D1
Van Rijckevorsel, K1
Gallez, B1
Hansen, SL1
Sperling, BB1
Sánchez, C1
Löscher, W1
Potschka, H1
Rieck, S1
Tipold, A1
Rundfeldt, C1
Seike, Y1
Hashikawa, K1
Oku, N2
Moriwaki, H1
Yamamoto, H1
Fukuchi, K1
Watanabe, Y1
Matsumoto, M1
Hori, M1
Nishimura, T2
Jäger, AK1
Mohoto, SP1
van Heerden, FR1
Viljoen, AM1
Hosseinzadeh, H1
Parvardeh, S1
Nassiri-Asl, M1
Mansouri, MT1
van Rij, CM1
Huitema, AD1
Swart, EL1
Greuter, HN1
van Loenen, AC1
Franssen, EJ1
Hodozuka, A1
Tsuda, H1
Hashizume, K1
Tanaka, T1
Ikeda, S1
Fukumitsu, N2
Ogi, S1
Uchiyama, M2
Mori, Y2
Kitagawa, K1
Kishima, H1
Saitoh, Y1
Kato, A1
Yoshimine, T1
Luat, AF1
Chugani, HT8
Savic, I3
Thorell, JO1
Roland, P1
Nagata, T1
Saji, H1
Nishizawa, S1
Yonekura, Y2
Yamamoto, I1
Iida, Y1
Magata, Y1
Konishi, J1
Serikawa, T1
Yokoyama, A1
Reisner-Keller, LA1
Pham, Z1
Schmidt, D1
Jibiki, I1
Kurokawa, K1
Matsuda, H2
Fukushima, T1
Tsuji, S1
Yamaguchi, N1
Hisada, K1
Sharief, MK1
Sander, JW5
Shorvon, SD3
Duncan, S1
Gillen, GJ1
Brodie, MJ1
Ingvar, M1
Stone-Elander, S2
Torizuka, K1
Uemura, K1
Toru, M1
Shinohara, Y1
Nakagawara, J1
Sakai, F1
Fukuyama, H1
Morimoto, K1
Sadzot, B1
Nakamura, F1
Suzuki, S1
Nishimura, S1
Yagi, K1
Seino, M1
Polc, P2
Jahromi, SS1
Facciponte, G1
Pelletier, MR1
Zhang, L1
Carlen, PL1
Koepp, MJ2
Richardson, MP3
Brooks, DJ3
Poline, JB1
Van Paesschen, W1
Friston, KJ2
Duncan, JS4
Henry, TR1
Sue, H1
Kawakami, K1
Decoo, D1
Destée, A1
Sisodiya, SM1
Ashburner, J1
Free, SL1
Lamusuo, S1
Ruottinen, HM1
Knuuti, J1
Härkönen, R1
Ruotsalainen, U1
Bergman, J1
Haaparanta, M1
Solin, O1
Mervaala, E1
Nousiainen, U1
Jääskeläinen, S1
Ylinen, A1
Kälviäinen, R1
Rinne, JK1
Vapalahti, M1
Rinne, JO1
Klitgaard, H1
Matagne, A1
Gobert, J1
Wülfert, E1
Juhász, C6
Nagy, F3
Muzik, O7
Watson, C5
Shah, J5
Chugani, DC6
da Silva, EA2
Kupsky, W1
Canady, A2
Niimura, K1
Shen, C2
von Stockhausen, HM1
Herholz, K2
Gates, J1
Frost, M1
Ritter, F1
Shah, A2
Rössler, AS1
Launay, JM1
Venault, P1
Dodd, RH2
Chapouthier, G1
Sand, P1
Kavvadias, D1
Feineis, D1
Riederer, P1
Schreier, P1
Kleinschnitz, M1
Czygan, FC1
Abou-Mandour, A1
Bringmann, G1
Beckmann, H1
Hammers, A1
Janisse, J1
Borbély, K1
Szelies, B1
Sobesky, J1
Pawlik, G1
Mielke, R1
Bauer, B1
Heiss, WD1
Ducić, I1
Hart, YM2
Meinardi, H2
Nutt, DJ3
Widén, L1
Peeters, BW1
Van Rijn, CM1
Titulaer, MN1
Vossen, JM1
Coenen, AM1
Beer, HF1
Bläuenstein, PA1
Hasler, PH1
Delaloye, B1
Riccabona, G1
Bangerl, I1
Hunkeler, W1
Bonetti, EP1
Pieri, L1
Richards, JG1
Brouillet, E1
Chavoix, C1
de la Sayette, V1
Hantraye, P1
Kunimoto, M1
Khalili-Varasteh, M1
Guibert, B1
Fournier, D1
Naquet, R1
Porter, RJ1
Scollo-Lavizzari, G1
Pedder, SC1
Wilcox, R1
Tuchek, JM1
Crawford, RD1
Johnson, DD1
Antimov, P1
Tournev, I2
Zhelyazkova, S2
Azmanov, DN1
Dimova, PS1
Radionova, M1
Bojinova, V1
Florez, L1
Smith, SJ1
Jablensky, A1
Mulley, J1
Scheffer, I1
Kalaydjieva, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Imaging After Stereotactic Radiosurgery for Brain Metastases or Primary Tumor Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease ?[NCT03068520]140 participants (Anticipated)Interventional2017-03-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

11 reviews available for flumazenil and Aura

ArticleYear
Performance of PET imaging for the localization of epileptogenic zone in patients with epilepsy: a meta-analysis.
    European radiology, 2021, Volume: 31, Issue:8

    Topics: Epilepsy; Epilepsy, Temporal Lobe; Flumazenil; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Im

2021
PET and SPECT in brain tumors and epilepsy.
    Neurosurgery clinics of North America, 2011, Volume: 22, Issue:2

    Topics: Brain; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Epilepsy; Flumazenil; Fluorodeoxyglu

2011
[Usefulness of 123I-iomazenil SPECT in pediatric patients with neurological disease].
    No to hattatsu = Brain and development, 2012, Volume: 44, Issue:1

    Topics: Brain; Epilepsy; Flumazenil; Humans; Iodine Radioisotopes; Nervous System Diseases; Radiopharmaceuti

2012
Molecular and diffusion tensor imaging of epileptic networks.
    Epilepsia, 2008, Volume: 49 Suppl 3

    Topics: Adolescent; Age Factors; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Child; Chronic Diseas

2008
Clobazam for treatment of intractable epilepsy: a critical assessment.
    Epilepsia, 1994, Volume: 35 Suppl 5

    Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Clinical Trials a

1994
Functional neuroimaging with positron emission tomography.
    Epilepsia, 1996, Volume: 37, Issue:12

    Topics: Anticonvulsants; Brain; Cerebrovascular Circulation; Deoxyglucose; Epilepsy; Epilepsy, Temporal Lobe

1996
Imaging and epilepsy.
    Brain : a journal of neurology, 1997, Volume: 120 ( Pt 2)

    Topics: Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Epilepsy; Flumazenil; Fluorodeoxyglucose

1997
PET studies in epilepsy.
    Acta neurologica Belgica, 1997, Volume: 97, Issue:3

    Topics: Brain; Carbon Radioisotopes; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Fentanyl; Flumaze

1997
Relationship between EEG and positron emission tomography abnormalities in clinical epilepsy.
    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 2000, Volume: 17, Issue:1

    Topics: Biomarkers; Brain Diseases; Brain Diseases, Metabolic; Electroencephalography; Epilepsy; Epilepsy, T

2000
Naturally occurring benzodiazepines: current status of research and clinical implications.
    European archives of psychiatry and clinical neuroscience, 2000, Volume: 250, Issue:4

    Topics: Animals; Anxiety; Benzodiazepines; Brain; Chromatography, High Pressure Liquid; Epilepsy; Flumazenil

2000
[Functional imaging (PET and SPECT) in epilepsy].
    Orvosi hetilap, 2001, Nov-04, Volume: 142, Issue:44

    Topics: Animals; Brain; Cerebrovascular Circulation; Epilepsy; Flumazenil; Fluorodeoxyglucose F18; GABA Modu

2001

Trials

8 trials available for flumazenil and Aura

ArticleYear
Quantification of human brain benzodiazepine receptors using [18F]fluoroethylflumazenil: a first report in volunteers and epileptic patients.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:12

    Topics: Adult; Brain; Epilepsy; Female; Flumazenil; Humans; Image Processing, Computer-Assisted; Male; Metab

2003
Evaluation of the use of a standard input function for compartment analysis of [123I]iomazenil data: factors influencing the quantitative results.
    Annals of nuclear medicine, 2004, Volume: 18, Issue:7

    Topics: Adolescent; Adult; Aged; Algorithms; Alzheimer Disease; Brain; Cerebrovascular Disorders; Epilepsy;

2004
The effect of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled study.
    Epilepsy research, 1993, Volume: 15, Issue:1

    Topics: Administration, Oral; Adult; Anticonvulsants; Double-Blind Method; Electroencephalography; Epilepsy;

1993
Lack of effect of concomitant clobazam on interictal 123I-iomazenil SPECT.
    Epilepsy research, 1993, Volume: 15, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Brain; Clobazam; Ep

1993
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 3)--Report on clinical usefulness in epilepsy].
    Kaku igaku. The Japanese journal of nuclear medicine, 1996, Volume: 33, Issue:3

    Topics: Adult; Brain; Epilepsy; Female; Flumazenil; GABA-A Receptor Agonists; Humans; Iodine Radioisotopes;

1996
[Assessment of cerebral benzodiazepine receptor distribution in epilepsy by 123I-iomazenil-SPECT].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1997, Volume: 57, Issue:1

    Topics: Adult; Amphetamines; Brain; Cerebrovascular Circulation; Epilepsy; Female; Flumazenil; Humans; Iodin

1997
Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex.
    Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:6

    Topics: Adolescent; Adult; Atrophy; Cerebral Cortex; Electroencephalography; Epilepsy; Female; Flumazenil; F

1997
The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study.
    Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:4

    Topics: Adult; Anticonvulsants; Brain; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination

1991

Other Studies

52 other studies available for flumazenil and Aura

ArticleYear
Intra-hippocampal microinjection of oxytocin produced antiepileptic effect on the pentylenetetrazol-induced epilepsy in rats.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:4

    Topics: Animals; Anticonvulsants; Diazepam; Epilepsy; Flumazenil; Hippocampus; Male; Microinjections; Oxytoc

2017
Double match of
    Acta neurochirurgica, 2018, Volume: 160, Issue:9

    Topics: Adolescent; Adult; Child; Epilepsy; Female; Flumazenil; Fluorodeoxyglucose F18; Humans; Magnetic Res

2018
Anticonvulsant effect of a natural compound alpha,beta-epoxy-carvone and its action on the nerve excitability.
    Neuroscience letters, 2008, Sep-26, Volume: 443, Issue:1

    Topics: Action Potentials; Animals; Anticonvulsants; Convulsants; Cyclohexane Monoterpenes; Disease Models,

2008
Changes in GABAA receptor properties in amygdala kindled animals: in vivo studies using [11C]flumazenil and positron emission tomography.
    Epilepsia, 2009, Volume: 50, Issue:1

    Topics: Amygdala; Animals; Electroencephalography; Epilepsy; Flumazenil; GABA Modulators; Kindling, Neurolog

2009
Lamina-specific changes in hippocampal GABA(A)/cBZR and mossy fibre sprouting during and following amygdala kindling in the rat.
    Neurobiology of disease, 2009, Volume: 35, Issue:3

    Topics: Amygdala; Animals; Autoradiography; Cell Count; Cell Death; Electric Stimulation; Electrodes, Implan

2009
Iomazenil hyperfixation in single photon emission computed tomography study of malformations of cortical development during infancy.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2011, Volume: 15, Issue:4

    Topics: Cerebral Cortex; Child, Preschool; Epilepsy; Flumazenil; Humans; Infant; Iodine Radioisotopes; Male;

2011
Neuroradiological and neurofunctional examinations for patients with 22q11.2 deletion.
    Neuropediatrics, 2011, Volume: 42, Issue:6

    Topics: Case-Control Studies; Child; Child, Preschool; DiGeorge Syndrome; Electroencephalography; Epilepsy;

2011
MR imaging-based correction for partial volume effect improves detectability of intractable epileptogenic foci on iodine 123 iomazenil brain SPECT images: an extended study with a larger sample size.
    AJNR. American journal of neuroradiology, 2012, Volume: 33, Issue:11

    Topics: Adult; Algorithms; Artifacts; Brain; Epilepsy; False Negative Reactions; Female; Flumazenil; Humans;

2012
Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain

2012
Piperine decreases pilocarpine-induced convulsions by GABAergic mechanisms.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 104

    Topics: Alkaloids; Amino Acids; Animals; Anticonvulsants; Antioxidants; Atropine; Benzodioxoles; Biogenic Mo

2013
Presurgical evaluation of epilepsy by brain diffusion: MR-detected effects of flumazenil on the epileptogenic focus.
    Epilepsia, 2003, Volume: 44, Issue:3

    Topics: Adult; Brain Mapping; Cerebral Cortex; Diffusion Magnetic Resonance Imaging; Epilepsy; Epilepsy, Tem

2003
Positron emission tomography in presurgical localization of epileptic foci.
    Ideggyogyaszati szemle, 2003, Jul-20, Volume: 56, Issue:7-8

    Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Electroencephalography; Epilepsy; Female; Flumazenil

2003
Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:1

    Topics: Animals; Anticonvulsants; Bicuculline; Convulsants; Dehydroepiandrosterone Sulfate; Diazepam; Dose-R

2004
Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Epilepsia, 2004, Volume: 45, Issue:10

    Topics: Animals; Anticonvulsants; Bromides; Chronic Disease; Disease Models, Animal; Dog Diseases; Dogs; Dru

2004
Activity of a traditional South African epilepsy remedy in the GABA-benzodiazepine receptor assay.
    Journal of ethnopharmacology, 2005, Jan-15, Volume: 96, Issue:3

    Topics: Animals; Anticonvulsants; Cerebral Cortex; Epilepsy; Flumazenil; Humans; In Vitro Techniques; Medici

2005
Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats.
    Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:4

    Topics: Animals; Anticonvulsants; Benzoquinones; Convulsants; Diazepam; Epilepsy; Flumazenil; Injections, In

2005
Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations.
    British journal of clinical pharmacology, 2005, Volume: 60, Issue:5

    Topics: Adult; Area Under Curve; Depressive Disorder; Epilepsy; Female; Flumazenil; GABA Modulators; Humans;

2005
Focal cortical dysplasia: pathophysiological approach.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2006, Volume: 22, Issue:8

    Topics: Adolescent; Animals; Animals, Newborn; Autoradiography; Behavior, Animal; Brain Diseases; Brain Mapp

2006
[Influence of benzodiazepines on 123I iomazenil SPECT].
    No to hattatsu = Brain and development, 2006, Volume: 38, Issue:4

    Topics: Adolescent; Benzodiazepines; Child; Child, Preschool; Epilepsy; Female; Flumazenil; Humans; Infant;

2006
Effects of diazepam on 125I-iomazenil-benzodiazepine receptor binding and epileptic seizures in the El mouse.
    Annals of nuclear medicine, 2006, Volume: 20, Issue:8

    Topics: Animals; Anticonvulsants; Autoradiography; Brain; Diazepam; Disease Models, Animal; Epilepsy; Flumaz

2006
MRI-based correction for partial-volume effect improves detectability of intractable epileptogenic foci on 123I-iomazenil brain SPECT images.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:3

    Topics: Adult; Artifacts; Brain; Epilepsy; Female; Flumazenil; Humans; Image Enhancement; Imaging, Three-Dim

2008
[11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions.
    Epilepsia, 1995, Volume: 36, Issue:12

    Topics: Adult; Electroencephalography; Epilepsy; Epilepsy, Frontal Lobe; Female; Flumazenil; Humans; Male; M

1995
[125I]iomazenil binding in the brains of spontaneously epileptic rats: an ex vivo quantitative autoradiographic study.
    Nuclear medicine and biology, 1995, Volume: 22, Issue:4

    Topics: Animals; Autoradiography; Brain; Cerebrovascular Circulation; Epilepsy; Flumazenil; Iodine Radioisot

1995
Oral flumazenil in the treatment of epilepsy.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:5

    Topics: Administration, Oral; Clinical Trials as Topic; Diazepam; Drug Therapy, Combination; Epilepsy; Epile

1995
Comparison of benzodiazepine receptor and regional cerebral blood flow imaging of epileptiform foci in hippocampal kindled rabbits: a preliminary report.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 48, Issue:2

    Topics: Animals; Autoradiography; Cerebrovascular Circulation; Epilepsy; Flumazenil; Hippocampus; Iodine Rad

1994
Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci.
    Journal of neurology, neurosurgery, and psychiatry, 1993, Volume: 56, Issue:6

    Topics: Adult; Analysis of Variance; Carbon Radioisotopes; Deoxyglucose; Electroencephalography; Epilepsy; F

1993
Neuroimaging in epilepsy: is there a future for positron emission tomography.
    Epilepsia, 1996, Volume: 37, Issue:6

    Topics: Brain; Carbon Radioisotopes; Deoxyglucose; Epilepsy; Flumazenil; Fluorine Radioisotopes; Fluorodeoxy

1996
Effects of clobazam and its active metabolite on GABA-activated currents in rat cerebral neurons in culture.
    Epilepsia, 1996, Volume: 37, Issue:8

    Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Cells, Cultured;

1996
Benzodiazepine antagonists reduce epileptiform discharges in rat hippocampal slices.
    Epilepsia, 1996, Volume: 37, Issue:10

    Topics: Animals; Carbolines; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electric

1996
Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis.
    Brain : a journal of neurology, 1996, Volume: 119 ( Pt 5)

    Topics: Adult; Binding, Competitive; Epilepsy; Female; Flumazenil; Hippocampus; Humans; Male; Middle Aged; R

1996
Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data.
    Brain : a journal of neurology, 1997, Volume: 120 ( Pt 11)

    Topics: Adolescent; Adult; Antidotes; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Child; Epilepsy;

1997
Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    European journal of pharmacology, 1998, Jul-24, Volume: 353, Issue:2-3

    Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Carbolines; Convulsants; Diazepam; Disease Mod

1998
[11C]Flumazenil PET in patients with epilepsy with dual pathology.
    Epilepsia, 1999, Volume: 40, Issue:5

    Topics: Adolescent; Adult; Carbon Radioisotopes; Cerebral Cortex; Electroencephalography; Epilepsy; Female;

1999
Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1999, Volume: 19, Issue:9

    Topics: Adolescent; Adult; Binding Sites; Child; Child, Preschool; Epilepsy; Female; Flumazenil; GABA Modula

1999
[11C]flumazenil PET: activity images versus parametric images for the detection of neocortical epileptic foci.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:12

    Topics: Adult; Carbon Radioisotopes; Cerebral Cortex; Child; Epilepsy; Female; Flumazenil; Humans; Male; Neo

1999
Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy.
    Neurology, 2000, Jan-11, Volume: 54, Issue:1

    Topics: Adolescent; Blood Glucose; Brain; Child; Child, Preschool; Electroencephalography; Epilepsy; Female;

2000
Changes in benzodiazepine binding in a subkindling situation.
    Epilepsia, 2000, Volume: 41, Issue:6

    Topics: Animals; Carbolines; Convulsants; Disease Models, Animal; Epilepsy; Flumazenil; GABA Antagonists; Ki

2000
Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy.
    Neurology, 2000, Sep-26, Volume: 55, Issue:6

    Topics: Adolescent; Adult; Child; Child, Preschool; Electroencephalography; Epilepsy; Female; Flumazenil; Fl

2000
Benzodiazepine-GABA(A) receptor binding is very low in dysembryoplastic neuroepithelial tumor: a PET study.
    Epilepsia, 2001, Volume: 42, Issue:10

    Topics: Adult; Amygdala; Brain Neoplasms; Carbon Radioisotopes; Cerebral Cortex; Epilepsy; Female; Flumazeni

2001
Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy.
    Epilepsia, 2001, Volume: 42, Issue:10

    Topics: Age Factors; Brain; Brain Mapping; Carbon Radioisotopes; Child; Child, Preschool; Epilepsy; Female;

2001
Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [(11)C]-flumazenil PET.
    European journal of neurology, 2002, Volume: 9, Issue:2

    Topics: Adult; Carbon Radioisotopes; Epilepsy; Female; Flumazenil; GABA Modulators; Humans; Magnetic Resonan

2002
Benzodiazepine antagonist flumazenil reduces bicuculline-induced enhancement of neuronal activity in the spinal cord.
    Neuropharmacology, 1991, Volume: 30, Issue:1

    Topics: Animals; Bicuculline; Cats; Epilepsy; Evoked Potentials; Flumazenil; Male; Motor Neurons; Receptors,

1991
Feasibility of reversing benzodiazepine tolerance with flumazenil.
    Lancet (London, England), 1991, Jan-19, Volume: 337, Issue:8734

    Topics: Adult; Benzodiazepines; Drug Tolerance; Electroencephalography; Epilepsy; Feasibility Studies; Fluma

1991
Flumazenil as an anti-epileptic agent.
    Lancet (London, England), 1991, Mar-23, Volume: 337, Issue:8743

    Topics: Diazepam; Drug Evaluation; Epilepsy; Flumazenil; Humans; Time Factors

1991
Diazepam and Ro 15-1788 increase absence epilepsy in WAG/Rij rats chronically exposed to diazepam.
    European journal of pharmacology, 1990, Mar-13, Volume: 178, Issue:1

    Topics: Animals; Diazepam; Electroencephalography; Epilepsy; Flumazenil; Hypnotics and Sedatives; Male; Rats

1990
In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1990, Volume: 31, Issue:6

    Topics: Animals; Brain; Cerebrovascular Circulation; Drug Stability; Epilepsy; Female; Flumazenil; Humans; I

1990
Anticonvulsant activity of the diaryltriazine, LY81067: studies using electroencephalographic recording and positron emission tomography.
    Neuropharmacology, 1989, Volume: 28, Issue:4

    Topics: Animals; Anticonvulsants; Behavior, Animal; Benzodiazepinones; Brain; Convulsants; Electroencephalog

1989
Mechanisms of action of new antiepileptic drugs.
    Epilepsia, 1989, Volume: 30 Suppl 1

    Topics: Acetamides; Acetates; Amines; Aminocaproates; Aminopyridines; Anti-Anxiety Agents; Anticonvulsants;

1989
The clinical anti-convulsant effects of flumazenil, a benzodiazepine antagonist.
    European journal of anaesthesiology. Supplement, 1988, Volume: 2

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Electroencephalography; Epilepsy; Female; Flumazenil; Huma

1988
Benzodiazepine antagonist Ro 15-1788 (flumazepil) attenuates the anticonvulsant activity of diazepam in epileptic fowl.
    Brain research, 1987, Oct-20, Volume: 424, Issue:1

    Topics: Animals; Chickens; Diazepam; Epilepsy; Female; Flumazenil; Male; Poultry Diseases

1987
Traditional practices and perceptions of epilepsy among people in Roma communities in Bulgaria.
    Epilepsy & behavior : E&B, 2020, Volume: 108

    Topics: Bulgaria; Child; Epilepsy; Female; Humans; Male; Medicine, Traditional; Perception; Roma; Social Sti

2020
Mosaicism of a missense SCN1A mutation and Dravet syndrome in a Roma/Gypsy family.
    Epileptic disorders : international epilepsy journal with videotape, 2010, Volume: 12, Issue:2

    Topics: Adolescent; Alleles; Electroencephalography; Epilepsy; Follow-Up Studies; Genetic Carrier Screening;

2010